about
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registryDiagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literatureProcalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysisTranscription in response to physical stress--clues to the molecular mechanisms of exercise-induced asthma.Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis.Quality of blood culture testing - a survey in intensive care units and microbiological laboratories across four European countriesMuscle ultrasound for early assessment of critical illness neuromyopathy in severe sepsisPrevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineProcalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia.Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.[Severe organic dysphagia after long-term ventilation in a patient with sepsis and multiorgan failure].Impairment of small somatic and autonomic nerve fibres in intensive care unit patients with severe sepsis and critical illness polyneuropathy--a single center controlled observational study.[Prevention and follow-up care of sepsis. 1st revision of S2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V., DSG) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche InterdisziMarkers of endothelial damage in organ dysfunction and sepsis.Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational studyTargeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patientsESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology.Markers for sepsis diagnosis: what is useful?Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated)Diagnosis of ventilator-associated pneumonia: a systematic review of the literature.The role of procalcitonin in febrile neutropenic patients: review of the literature.The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomesStudy protocol: prediction of stroke associated infections by markers of autonomic control.Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?Rehabilitation interventions for postintensive care syndrome: a systematic review.[Peripheral venous catheter-related E. faecalis sepsis with fatal outcome].Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation.Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.Blood glucose measurements in the critically ill: more than just a blood draw.Mass spectometry-based protein patterns in the diagnosis of sepsis/systemic inflammatory response syndrome.Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock.Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).[Tight glucose control in intensive care patients--contra].Hydroxyethyl starches: Plus ça change, plus c'est la même chose.Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock.Kinetics of procalcitonin in iatrogenic sepsis.Current practice in nutritional support and its association with mortality in septic patients--results from a national, prospective, multicenter study.[How many nosocomial infections are avoidable?].Enteral nutrition is associated with improved outcome in patients with severe sepsis. A secondary analysis of the VISEP trial.
P50
Q21194917-F4B2DB18-7EFA-4C6B-8313-E01DA1047676Q21195047-48F8F179-27C2-4C74-9A5C-8C8DE674A1FBQ27028085-31B3E631-9E5A-48BF-B546-B383D0532E70Q33219818-08981E32-1C82-4658-B141-9C13AB37ABB2Q33341419-ED0B19AF-7596-4423-980C-997B72799BF5Q33750097-76562EE9-C334-4DA0-875E-87AC6730E75AQ33754428-086F5F26-9D28-445B-B4C5-30081B7212EAQ33974292-E84BF655-3E36-4332-B86D-4FCFCDBA5D9AQ34123643-F67F858B-0B7D-41D1-AEF8-11323A7CC84EQ34280888-63CB2E81-6CCC-48C8-B828-0798F21C9ABDQ34325775-47BD5FA7-48C1-4655-B331-432A0E2B4285Q34409319-677925CB-BA1E-4BE9-B2F7-D13520042E4DQ34493612-C2B6B94B-4681-4BBD-8BF9-0710C7EB4A30Q34621790-67866D4E-B287-41F0-8740-813115071AE9Q34633607-D7B410C6-F98E-4D04-9A42-101F761499EAQ35559416-CB9E493E-B604-429C-BC21-BD28C30C8A29Q36020293-94297518-5DD1-4D90-BD5F-BDC84CDD3822Q36476963-FFBE55DB-952F-4C9C-9794-10EB4BF504ABQ36558938-98A72BAD-05B0-4607-9FD1-EFAAA0F786E3Q36749051-7E0209A1-E586-44CE-8861-32B10BC31FA0Q36749132-7BF33DBE-6122-4B1F-8078-85EBD072FF71Q37256588-B37DC83C-2C61-49FE-85AC-42A0E11EEC95Q37279933-0EA283B1-CDD0-4895-91DD-EEE8108DF42CQ37509849-B1FDE1CB-E5F3-4D48-B360-EFBE86355C25Q37848139-3C7B4C61-F466-4E2A-A794-DBDC0611D7D5Q38177637-A9659404-C47E-4BD2-BCBE-CF8FF544B2E5Q40238374-083838FB-BC93-4799-A5DA-0EAD0E5CB412Q40627510-7101CFB0-1684-423F-955D-168F3123A536Q42165275-FEF8DDEC-AEEF-4B36-A011-776FD58D225CQ42251924-2059D342-D2FF-40BF-95F8-947F1AAD3AF2Q42620006-29631AAB-140D-447C-9522-B2AA43308C32Q42654082-02DFF535-95F4-4188-BD32-BD9826872E6FQ42654905-E1D31AE2-DFFD-4768-AC92-EC473915CD11Q43112428-40544D05-5A3D-41CF-92E2-0797D4D1DC3DQ43152399-BADB6E48-FF8B-4B69-988F-CCDA32132AD1Q43275564-1538CAB3-19D6-4783-88BF-402C018EA634Q43523650-33CCF1FD-7343-45A4-9FE4-6827B0F8521BQ43553784-3F0FBC6A-C881-4753-998E-DDE923A35EA6Q43638153-957FE32D-A11C-40E6-A103-38F0F5B37D26Q43721306-D00DEC64-1653-4650-98FB-CE88376B54DE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Frank Brunkhorst
@ast
Frank Brunkhorst
@en
Frank Brunkhorst
@es
Frank Brunkhorst
@fr
Frank Brunkhorst
@nl
Frank Brunkhorst
@sl
type
label
Frank Brunkhorst
@ast
Frank Brunkhorst
@en
Frank Brunkhorst
@es
Frank Brunkhorst
@fr
Frank Brunkhorst
@nl
Frank Brunkhorst
@sl
prefLabel
Frank Brunkhorst
@ast
Frank Brunkhorst
@en
Frank Brunkhorst
@es
Frank Brunkhorst
@fr
Frank Brunkhorst
@nl
Frank Brunkhorst
@sl
P214
P244
P106
P21
P214
P244
n2012180958
P31
P496
0000-0002-8132-8651
P734
P735
P7859
lccn-n2012180958